Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Technology effectively detects harsh side effect of breast cancer treatment

Some 20 percent of breast cancer survivors will suffer from lymphedema, a potentially severe side effect of treatment that makes arms swell with lymph. The disease is often overlooked, but commercially available app-based technology now makes early detection easier, allowing for proactive treatment.

16 Mar 2020

Scientists discover link between Parkinson's and gene targeted by blue-green algae toxin

Scientists have discovered a possible link between Parkinson's disease and a gene impacted by a neurotoxin found in blue-green algae.

16 Mar 2020

Blood stem cells conserve epigenetic memory of previous infections to boost immunity

These findings should have a significant impact on future vaccination strategies and pave the way for new treatments of an underperforming or over-reacting immune system. The results of this research are published in Cell Stem Cell on March 12, 2020.

13 Mar 2020

NTHU research team develops new treatment for Parkinson’s disease

Ultrasound is widely used for conducting physical examinations, and plans are underway for expanding its application to the treatment of Parkinson's disease, dementia, and diabetes.

12 Mar 2020

Protective brain-cell housekeeping mechanism may also be involved in regulating sleep

An important biological mechanism that is thought to protect brain cells from neurodegenerative diseases such as Alzheimer's and Parkinson's may also be involved in regulating sleep, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

12 Mar 2020

Researchers probe how specific genes can impact early brain development

When brains begin developing, there are a lot of moving parts -- and when mutations happen in early neurodevelopment, it can lead to disorders like macrocephaly and autism.

11 Mar 2020

Stress-linked disorders increase the risk of later brain degeneration

A new study published in the journal JAMA Neurology in March 2020 suggests that stress-related disorders increase the risk of later development of dementia and other neurodegenerative disorders.

9 Mar 2020

Study shows how series of ‘clutches’ in the motor cortex help our brains initiate movement

For decades, scientists have wondered why specific cells in the brain that control movement fire when people simply plan or imagine making a movement, or observe someone else making a movement - but do not actually move themselves.

7 Mar 2020

New findings could shed light on pathologies in brain signaling

Our day-to-day lives can be seen as a series of complex motor sequences: morning routines, work or school tasks, actions we take around mealtimes, the rituals and habits woven through our evenings and weekends.

6 Mar 2020

Researchers uncover novel neurotransmitter system in the brain

Neurotransmitters are chemicals that transmit signals between neurons or from neurons to other cells. They interact with specific receptors found in the brain of humans and animals, controlling a variety of biological processes, e.g. fear, anger, pleasure, memory, energy, appetite and sleep.

5 Mar 2020

Experimental drug offers hope for improving movement symptoms of Parkinson's

Results from a study looking at an experimental drug to tackle the debilitating side effect of dyskinesia, have offered hope that it may have potential as a future treatment for people with Parkinson's.

2 Mar 2020

People eating a vegetarian diet rich in nuts, vegetables, soy may have lower risk of stroke

People who eat a vegetarian diet rich in nuts, vegetables and soy may have a lower risk of stroke than people who eat a diet that includes meat and fish, according to a study published in the February 26, 2020, online issue of Neurology, the medical journal of the American Academy of Neurology.

28 Feb 2020

Study shows how habits can be controlled based on the activity of the brain region

Each day, humans and animals rely on habits to complete routine tasks such as eating and sleeping. As new habits are formed, this enables us to do things automatically without thinking.

28 Feb 2020

Gene-editing technology may lead to new model for studying Parkinson’s disease

Parkinson's disease researchers have used gene-editing tools to introduce the disorder's most common genetic mutation into marmoset monkey stem cells and to successfully tamp down cellular chemistry that often goes awry in Parkinson's patients.

27 Feb 2020

New radiotracer to improve image-based differential diagnostics of Parkinson’s disease

An interdisciplinary team from the Institute of Radiopharmaceutical Cancer Research headed by Prof. Peter Brust has won HZDR's (Helmholtz-Zentrum Dresden-Rossendorf) third Innovation Contest.

27 Feb 2020

Renishaw completes main part of Phase 1-2 clinical trial along with Herantis Pharma for treatment of Parkinson’s disease

Global engineering technologies company, Renishaw, announces that its award-winning intraparenchymal drug delivery device, has played a critical role in a joint Phase 1-2 clinical study with Herantis Pharma plc, for the investigation of cerebral dopamine neurotrophic factor (CDNF)as a treatment for Parkinson's disease.

27 Feb 2020

Renishaw Announces Completion of the Main Part of a Multi-Centre Clinical Trial Jointly Undertaken with Herantis Pharma plc for the Treatment of Parkinson’s Disease Patients

Renishaw, announces that its drug delivery device has played a critical role in the investigation CDNF as a treatment for Parkinson's disease.

From Renishaw plc - Additive Manufacturing for Healthcare Applications 26 Feb 2020

Language may be a promising biomarker for progression of Hungtinton's disease

Huntington's disease is a hereditary neurodegenerative disorder caused by a gene of chromosome 4 that affects a very important area of the brain, the striatum. People are born with the defective gene but symptoms do not appear until the age of 30 or 40.

20 Feb 2020

Increase in out-of-pocket costs associated with lower adherence to neurologic medications

As out-of-pocket costs go up for drugs for the neurologic disorders Alzheimer's disease, peripheral neuropathy and Parkinson's disease, people are less likely to take the drugs as often as their doctors prescribed, according to a study funded by the American Academy of Neurology and published in the February 19, 2020, online issue of Neurology, the medical journal of the American Academy of Neurology.

19 Feb 2020

Live-cell imaging provides new insights into dynamic structure of mitochondria

As power plants and energy stores, mitochondria are essential components of almost all cells in plants, fungi and animals. Until now, it has been assumed that these functions underlie a static structure of mitochondrial membranes.

18 Feb 2020

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Technology effectively detects harsh side effect of breast cancer treatment

Scientists discover link between Parkinson's and gene targeted by blue-green algae toxin

Blood stem cells conserve epigenetic memory of previous infections to boost immunity

NTHU research team develops new treatment for Parkinson’s disease

Protective brain-cell housekeeping mechanism may also be involved in regulating sleep

Researchers probe how specific genes can impact early brain development

Stress-linked disorders increase the risk of later brain degeneration

Study shows how series of ‘clutches’ in the motor cortex help our brains initiate movement

New findings could shed light on pathologies in brain signaling

Researchers uncover novel neurotransmitter system in the brain

Experimental drug offers hope for improving movement symptoms of Parkinson's

People eating a vegetarian diet rich in nuts, vegetables, soy may have lower risk of stroke

Study shows how habits can be controlled based on the activity of the brain region

Gene-editing technology may lead to new model for studying Parkinson’s disease

New radiotracer to improve image-based differential diagnostics of Parkinson’s disease

Renishaw completes main part of Phase 1-2 clinical trial along with Herantis Pharma for treatment of Parkinson’s disease

Renishaw Announces Completion of the Main Part of a Multi-Centre Clinical Trial Jointly Undertaken with Herantis Pharma plc for the Treatment of Parkinson’s Disease Patients

Language may be a promising biomarker for progression of Hungtinton's disease

Increase in out-of-pocket costs associated with lower adherence to neurologic medications

Live-cell imaging provides new insights into dynamic structure of mitochondria

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Newsletters you may be interested in